Literature DB >> 4123817

Myocardial and circulatory effects of E. coli endotoxin; modification of responses to catecholamines.

J R Parratt.   

Abstract

1. The predominant acute effect of E. coli endotoxin in anaesthetized, ventilated cats was pulmonary hypertension resulting from a 8-12 fold increase in pulmonary vascular resistance. This was followed by decreases in left ventricular (LV) and systemic arterial pressures and in LV dP/dt max. Recovery occurred within 2-4 min and was dependent upon increased sympathetic drive; recovery did not occur in cats treated with the beta-adrenoceptor blocking drug alprenolol.2. The pulmonary vasoconstriction was reduced in cats given compound 48/80 and evidence is presented that it results primarily from histamine release.3. Over the 2-3 h period following endotoxin injection, systemic arterial pressure tended to decrease and heart rate and myocardial metabolic heat production to increase. Myocardial blood flow and LV dP/dt remained fairly stable until the terminal stages of shock.4. The predominant delayed effect of E. coli endotoxin in cats were a markedly reduced stroke volume, an increase in peripheral vascular resistance and a severe metabolic acidosis (arterial base excess-20 mEq/litre). Arterial pO(2) and pCO(2) were not significantly affected. It is concluded that myocardial contractility is maintained at this time through the release of catecholamines and that endotoxin itself depresses contractility.5. The effects of adrenaline and noradrenaline infusions on systolic and diastolic blood pressures, heart rate, cardiac output, myocardial blood flow and LV dP/dt max were markedly reduced in the period 2-3 h after endotoxin. In a few animals some recovery of the response to noradrenaline occurred and was associated with a general circulatory improvement and a reduced metabolic acidosis.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4123817      PMCID: PMC1776526          DOI: 10.1111/j.1476-5381.1973.tb08154.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  32 in total

1.  Mechanisms of the hemodynamic effects of endotoxin.

Authors:  R P GILBERT
Journal:  Physiol Rev       Date:  1960-04       Impact factor: 37.312

2.  Myocardial blood flow in the rabbit.

Authors:  J GRAYSON; D MENDEL
Journal:  Am J Physiol       Date:  1961-05

3.  5-Hydroxytryptamine and tissue mast cells.

Authors:  J R PARRATT; G B WEST
Journal:  J Physiol       Date:  1957-07-11       Impact factor: 5.182

4.  Effect of gram-negative endotoxin on pulmonary circulation.

Authors:  H KUIDA; L B HINSHAW; R P GILBERT; M B VISSCHER
Journal:  Am J Physiol       Date:  1958-02

5.  Effects of endotoxin on distribution of cardiac output in unanesthetized rabbits.

Authors:  F Wyler; J M Neutze; A M Rudolph
Journal:  Am J Physiol       Date:  1970-07

6.  Relationship between splanchnic blood flow and a myocardial depressant factor in endotoxin shock.

Authors:  S L Wangensteen; W T Geissinger; W L Lovett; T M Glenn; A M Lefer
Journal:  Surgery       Date:  1971-03       Impact factor: 3.982

7.  Separation of acute and delayed hemodynamic responses to endotoxin in the cat.

Authors:  C V Greenway; W W Lautt; R D Stark
Journal:  Am J Physiol       Date:  1969-08

8.  The effect of noradrenaline on the calcium uptake of the sarcoplasmic reticulum.

Authors:  E A Shinebourne; M L Hess; R J White; J Hamer
Journal:  Cardiovasc Res       Date:  1969-04       Impact factor: 10.787

9.  Studies on the mode of action of hexobendine, a prospective anti-anginal drug.

Authors:  L McInnes; J R Parratt
Journal:  Br J Pharmacol       Date:  1969-09       Impact factor: 8.739

10.  Noradrenaline and tyramine action on isolated atrial muscle of endotoxin-treated guinea-pigs.

Authors:  B Bhagat; D Cavanagh; B N Merrild; M W Rana; P S Rao
Journal:  Br J Pharmacol       Date:  1970-08       Impact factor: 8.739

View more
  42 in total

1.  The protective effect of sodium meclofenamate in experimental endotoxin shock.

Authors:  J R Parratt; R M Sturgess
Journal:  Br J Pharmacol       Date:  1975-03       Impact factor: 8.739

2.  Behaviour of short and long latency components of the stretch reflex in human muscle.

Authors:  C D Marsden; P A Merton; H B Morton
Journal:  J Physiol       Date:  1975-03       Impact factor: 5.182

3.  Effects of AM281, a cannabinoid antagonist, on circulatory deterioration and cytokine production in an endotoxin shock model: comparison with norepinephrine.

Authors:  Yuji Kadoi; Fumio Goto
Journal:  J Anesth       Date:  2006       Impact factor: 2.078

4.  The effects of the protease inhibitor, aprotinin, on the course of shock induced by endotoxin in cats.

Authors:  B Hughes; J R Parratt
Journal:  Br J Pharmacol       Date:  1985-10       Impact factor: 8.739

5.  E. coli endotoxin shock in the cat; treatment with indomethacin.

Authors:  J R Parratt; R M Sturgess
Journal:  Br J Pharmacol       Date:  1975-04       Impact factor: 8.739

6.  Impaired pressor sensitivity to noradrenaline in septic shock patients with and without impaired adrenal function reserve.

Authors:  D Annane; E Bellissant; V Sebille; O Lesieur; B Mathieu; J C Raphael; P Gajdos
Journal:  Br J Clin Pharmacol       Date:  1998-12       Impact factor: 4.335

7.  Prostaglandins and thromboxane in the delayed phase of shock induced by Serratia marcescens endotoxin.

Authors:  J R Parratt; N Sharma; I J Zeitlin
Journal:  Br J Pharmacol       Date:  1984-05       Impact factor: 8.739

8.  Feline endotoxin shock: effects of methylprednisolone on kininogen-depletion, on the pulmonary circulation and on survival.

Authors:  N Al-Kaisi; J R Parratt; H H Siddiqui; I J Zeitlin
Journal:  Br J Pharmacol       Date:  1977-07       Impact factor: 8.739

9.  Failure of drugs that selectively inhibit thromboxane synthesis to modify endotoxin shock in conscious rats.

Authors:  B L Furman; K McKechnie; J R Parratt
Journal:  Br J Pharmacol       Date:  1984-05       Impact factor: 8.739

10.  A new canine model of endotoxin shock.

Authors:  S F Evans; C J Hinds; J G Varley
Journal:  Br J Pharmacol       Date:  1984-10       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.